Key facts
- Notable investors include Start Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for StandardX
- ·The full record, as it builds
Funding rounds
No funding rounds for StandardX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About StandardX
Operator of an isotope production company intended to secure the global supply of rare isotopes essential for medicine, industry and energy. The company offers a scalable isotope production platform that transforms breakthrough physics into practical infrastructure, enabling customers to access critical isotopes for cancer treatment, industrial resilience and fusion energy development.
- Sector
- Business Products and Services (B2B)
- HQ
- London, United Kingdom
- Founded
- 2025
- Website
- standardx.tech/
- Ownership
- Privately Held (backing)
StandardX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in StandardX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on StandardX in its N-PORT filings yet. We sweep new filings monthly.